These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 28288703)

  • 1. Erratum to "Prevalence, predictors and prognosis of ventricular reverse remodeling in idiopathic dilated cardiomyopathy" (Rev. Port. Cardiol. 2016;35(5):253-260).
    Amorim S; Campelo M; Martins E; Moura B; Sousa A; Pinho T; Silva-Cardoso J; Maciel MJ
    Rev Port Cardiol; 2017 Mar; 36(3):231. PubMed ID: 28288703
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment.
    Merlo M; Pyxaras SA; Pinamonti B; Barbati G; Di Lenarda A; Sinagra G
    J Am Coll Cardiol; 2011 Mar; 57(13):1468-76. PubMed ID: 21435516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum to "Heart transplantation for Chagas cardiomyopathy" (Rev. Port. Cardiol. 2017;36(11):871.e1-871.e4).
    Ramalho AR; Prieto D; Antunes P; Franco F; Antunes MJ
    Rev Port Cardiol (Engl Ed); 2018 Jan; 37(1):95. PubMed ID: 29428050
    [No Abstract]   [Full Text] [Related]  

  • 6. Left ventricular reverse remodeling in long-term (>12 years) survivors with idiopathic dilated cardiomyopathy.
    Matsumura Y; Hoshikawa-Nagai E; Kubo T; Yamasaki N; Furuno T; Kitaoka H; Takata J; Sugiura T; Doi Y
    Am J Cardiol; 2013 Jan; 111(1):106-10. PubMed ID: 23040590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of right ventricular function in paediatric idiopathic dilated cardiomyopathy.
    Groner A; Yau J; Lytrivi ID; Ko HH; Nielsen JC; Parness IA; Srivastava S
    Cardiol Young; 2013 Jun; 23(3):409-15. PubMed ID: 22914442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical ventricular reverse remodeling in severe ischemic dilated cardiomyopathy: the relevance of the left ventricular equator as a prognostic factor.
    Ferrazzi P; Matteucci ML; Merlo M; Iacovoni A; Rescigno G; Bottai M; Parrella P; Lorini L; Senni M; Gavazzi A
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):357-63. PubMed ID: 16434265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in advanced dilated cardiomyopathy.
    De Bonis M; Lapenna E; Verzini A; La Canna G; Grimaldi A; Torracca L; Maisano F; Alfieri O
    Ann Thorac Surg; 2008 Mar; 85(3):932-9. PubMed ID: 18291174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry.
    Foerster SR; Canter CE; Cinar A; Sleeper LA; Webber SA; Pahl E; Kantor PF; Alvarez JA; Colan SD; Jefferies JL; Lamour JM; Margossian R; Messere JE; Rusconi PG; Shaddy RE; Towbin JA; Wilkinson JD; Lipshultz SE
    Circ Heart Fail; 2010 Nov; 3(6):689-97. PubMed ID: 20833772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic respiratory illness as a predictor of survival in idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study.
    Martin SA; Coughlin SS; Metayer C; René AA; Hammond IW
    J Natl Med Assoc; 1996 Nov; 88(11):734-43. PubMed ID: 8961693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy.
    Fauchier L; Babuty D; Poret P; Casset-Senon D; Autret ML; Cosnay P; Fauchier JP
    Eur Heart J; 2000 Feb; 21(4):306-14. PubMed ID: 10653678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist?
    Merlo M; Stolfo D; Anzini M; Negri F; Pinamonti B; Barbati G; Ramani F; Lenarda AD; Sinagra G
    J Am Heart Assoc; 2015 Jan; 4(1):e001504. PubMed ID: 25587018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy.
    Sarli B; Topsakal R; Kaya EG; Akpek M; Lam YY; Kaya MG
    J Investig Med; 2013 Apr; 61(4):728-32. PubMed ID: 23429699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular dysfunction in patients with idiopathic dilated cardiomyopathy: Prognostic value and predictive factors.
    Venner C; Selton-Suty C; Huttin O; Erpelding ML; Aliot E; Juillière Y
    Arch Cardiovasc Dis; 2016 Apr; 109(4):231-41. PubMed ID: 26782624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy.
    Bobbo M; Pinamonti B; Merlo M; Stolfo D; Iorio A; Ramani F; Barbati G; Carriere C; Massa L; Poli S; Scapol S; Gigli M; Di Lenarda A; Sinagra G
    Am J Cardiol; 2017 Feb; 119(3):483-489. PubMed ID: 27988039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Matsumura Y; Hoshikawa-Nagai E; Kubo T; Yamasaki N; Kitaoka H; Takata J; Doi Y; Sugiura T
    Cardiovasc Ultrasound; 2015 Mar; 13():14. PubMed ID: 25880063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical predictors of reverse remodeling in patients with dilated cardiomyopathy.
    Arad M; Nussbaum T; Blechman I; Feinberg MS; Koren-Morag N; Peled Y; Freimark D
    Isr Med Assoc J; 2014 Jul; 16(7):405-11. PubMed ID: 25167684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procollagen type III amino-terminal propeptide: a serum biomarker of left ventricular remodelling in paediatric dilated cardiomyopathy.
    Kaufman BD; Videon N; Zhang X; Harris MA; Shaddy RE; Goldmuntz E
    Cardiol Young; 2015 Feb; 25(2):228-36. PubMed ID: 24192074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.